QQ客服 官方微博 反馈留言

	Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorectal cancer
	Zhang, Wen-Ji[1,2]; Li, Yong[3]; Wei, Meng-Ning[1,2]; Chen, Yao[1,2]; Qiu, Jian-Ge[1,2]; Jiang, Qi-Wei[1,2]; Yang, Yang[1,2]; Zheng, Di-Wei[1,2]; Qin, Wu-Ming[1,2]; Huang, Jia-Rong[1,2]
	2017
卷号	386期号:[db:dc_citation_issue]页码:100
DOI	[db:dc_identifier_doi]
URL标识	查看原文
WOS记录号	[DB:DC_IDENTIFIER_WOSID]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3355730
专题	暨南大学
作者单位	1.[1]Jinan Univ, Dept Cell Biol, Guangzhou 510632, Guangdong, Peoples R China 2.[2]Jinan Univ, Inst Biomed, Natl Engn Res Ctr Genet Med, Guangdong Prov Key Lab Bioengn Med,Coll Life Sci, Guangzhou 510632, Guangdong, Peoples R China 3.[3]Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Gastrointestinal Surg & Gen Surg, Guangzhou 510080, Guangdong, Peoples R China 4.[4]Jinan Univ, Dept Prevent Med, Coll Med, Guangzhou 510632, Guangdong, Peoples R China 5.[5]St Johns Univ, Dept Pharmaceut Sci, Coll Pharm & Hlth Sci, Queens, NY 11439 USA 6.[6]Jinan Univ, Coll Pharm, Guangdong Prov Key Lab Pharmacodynam Constituents, Guangzhou 510632, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Zhang, Wen-Ji[1,2],Li, Yong[3],Wei, Meng-Ning[1,2],et al. Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorectal cancer[J],2017,386([db:dc_citation_issue]):100.
APA	Zhang, Wen-Ji[1,2].,Li, Yong[3].,Wei, Meng-Ning[1,2].,Chen, Yao[1,2].,Qiu, Jian-Ge[1,2].,...&Shi, Zhi[1,2].(2017).Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorectal cancer.,386([db:dc_citation_issue]),100.
MLA	Zhang, Wen-Ji[1,2],et al."Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorectal cancer".386.[db:dc_citation_issue](2017):100.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。